SpineDAO’s April fundraising auction on Solana blockchain secured over $200,000 with its curation round filling in under six hours, positioning it among the first decentralized biomedical collectives on this blockchain. Simultaneously, the organization advanced key healthcare projects and expanded global partnerships.

As the quest for extended human healthspan and lifespan continues, the limitations of current medical technology in significantly prolonging maximal lifespan are becoming increasingly apparent. In this context, cryopreservation, or human biostasis, is emerging as a critical alternative for those seeking a chance at future revival. CryoDAO is positioned at the forefront of this pioneering field, actively initiating and funding ambitious research projects designed to overcome the current hurdles in cryopreservation and make reversible human biostasis a reality. This article explores the rationale behind cryopreservation, the scientific processes involved, and CryoDAO’s pivotal role in advancing this potentially life-altering technology.

In its 2024 performance summary, VitaDAO has documented remarkable advancements in funding and developing early-stage longevity research. The report outlines scientific innovations, commercial progress, and fundamental programs designed to lengthen healthy human life. Notable achievements include a 250% expansion in token ownership year-over-year, progress in research initiatives targeting age-associated conditions, and the successful introduction of new ventures such as VitaLabs

Bithumb, a leading cryptocurrency platform in South Korea, has incorporated Hippocrat (HPO) into its trading roster alongside Adventure Gold (AGLD) and Cobak Token (CBK). This integration onto a major Korean exchange represents a crucial advancement in Hippocrat's international market strategy. The blockchain-based healthcare data protocol now enjoys increased accessibility for Korean investors seeking involvement in decentralized science (DeSci) initiatives, potentially accelerating adoption of its innovative medical data solutions throughout the region.